原始脑出血评分预测脑出血短期死亡率的系统评价与Meta分析
该系统评价与Meta分析纳入55项提供区分度数据、35项提供校准度数据的研究,评估原始脑出血评分对成人非创伤性脑出血1个月/出院或更早死亡率的预测效能。汇总C统计量为0.84(95%CI 0.82-0.85),区分度良好;但汇总观察:预期死亡率比为0.87(95%CI 0.78-0.97),提示评分高估死亡率,两项估计异质性均高(I²分别为80%和84%)。区分度受研究平均脑出血评分影响(β=-0.05),校准度受疾病严重程度影响,评分>3分患者观察:预期死亡率比为0.84(95%CI 0.78-0.91)。评分0-1分患者的死亡率在各队列间可重复(I²=15%)。作者认为脑出血评分是有效的短期死亡率临床预测规则,但对重症队列区分度较差,且高估高分患者死亡率,提示这些患者的死亡率取决于评分未纳入的因素,需进一步研究确定。
要点
- 脑出血评分对成人非创伤性脑出血短期死亡率区分度良好,汇总C统计量0.84(95%CI 0.82-0.85)。
- 评分整体高估死亡率,汇总观察:预期死亡率比0.87(95%CI 0.78-0.97),异质性高(I²=80%和84%)。
- 评分>3分患者死亡率被高估更明显,观察:预期死亡率比0.84(95%CI 0.78-0.91)。
- 评分0-1分患者死亡率在各队列间可重复(I²=15%)。
- 区分度受研究平均脑出血评分影响(β=-0.05),重症队列区分度更差。
适用人群与场景
- 成人非创伤性脑出血患者,评估1个月/出院或更早的短期死亡率预测。
诊断标准与关键阈值
- 原始脑出血评分(Intracerebral Hemorrhage score)用于预测短期死亡率。
研究设计与关键结果
- 系统评价与Meta分析,检索PubMed、ISI Web of Knowledge、Scopus和CENTRAL自建库至2018年9月15日,纳入55项提供区分度数据、35项提供校准度数据的研究。
- 汇总C统计量0.84(95%CI 0.82-0.85),区分度良好,异质性I²=80%。
- 汇总观察:预期死亡率比0.87(95%CI 0.78-0.97),提示评分高估死亡率,异质性I²=84%。
- 区分度受研究平均脑出血评分影响(β=-0.05)。
- 校准度受疾病严重程度影响,评分>3分患者观察:预期死亡率比0.84(95%CI 0.78-0.91)。
- 评分0-1分患者死亡率在各队列间可重复(I²=15%)。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析。
- 局限:两项汇总估计异质性均高(I²分别为80%和84%);作者指出需进一步研究确定评分未纳入的因素。
对床旁实践的改变
- 作者认为脑出血评分是有效的短期死亡率临床预测规则,但对重症队列区分度较差,且高估高分患者死亡率,提示这些患者的死亡率取决于评分未纳入的因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To systematically assess the discrimination and calibration of the Intracerebral Hemorrhage score for prediction of short-term mortality in intracerebral hemorrhage patients and to study its determinants using heterogeneity analysis.
DATA SOURCES: PubMed, ISI Web of Knowledge, Scopus, and CENTRAL from inception to September 15, 2018.
STUDY SELECTION: Adult studies validating the Intracerebral Hemorrhage score for mortality prediction in nontraumatic intracerebral hemorrhage at 1 month/discharge or sooner.
DATA EXTRACTION: Data were collected on the following aspects of study design: population studied, level of care, timing of outcome measurement, mean study year, and mean cohort Intracerebral Hemorrhage score. The summary measures of interest were discrimination as assessed by the C-statistic and calibration as assessed by the standardized mortality ratio (observed:expected mortality ratio). Random effect models were used to pool both measures. Heterogeneity was measured using the I statistic and explored using subgroup analysis and meta-regression.
DATA SYNTHESIS: Fifty-five studies provided data on discrimination, and 35 studies provided data on calibration. Overall, the Intracerebral Hemorrhage score discriminated well (pooled C-statistic 0.84; 95% CI, 0.82-0.85) but overestimated mortality (pooled observed:expected mortality ratio = 0.87; 95% CI, 0.78-0.97), with high heterogeneity for both estimates (I 80% and 84%, respectively). Discrimination was affected by study mean Intracerebral Hemorrhage score (β = -0.05), and calibration was affected by disease severity, with the score overestimating mortality for patients with an Intracerebral Hemorrhage score greater than 3 (observed:expected mortality ratio = 0.84; 95% CI, 0.78-0.91). Mortality rates were reproducible across cohorts for patients with an Intracerebral Hemorrhage score 0-1 (I = 15%).
CONCLUSIONS: The Intracerebral Hemorrhage score is a valid clinical prediction rule for short-term mortality in intracerebral hemorrhage patients but discriminated mortality worse in more severe cohorts. It also overestimated mortality in the highest Intracerebral Hemorrhage score patients, with significant inconsistency between cohorts. These results suggest that mortality for these patients is dependent on factors not included in the score. Further studies are needed to determine these factors.
参考来源
- Gregório T, Pipa S, Cavaleiro P, et al. Original Intracerebral Hemorrhage Score for the Prediction of Short-Term Mortality in Cerebral Hemorrhage: Systematic Review and Meta-Analysis. Crit Care Med. 2019. PMID: 30889025. doi:10.1097/CCM.0000000000003744
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。